glp-1 treatment 3 Takeaways from the Landmark Oral 'Switch' Trial for Obesity Care GLP-1 receptor agonists | How
Description
Obtaining drug approval via the traditional NDA pathway can take years (often up to 15 years) and cost millions of dollars
To continue enjoying this article, please sign in
In parallel, emerging evidence suggests that the range of action of GLP-1 on reward behavior is not limited to food-derived reward but extends to cocaine, amphetamine, and alcohol reward
These findings offer new hope for people with chronic kidney disease
Obesity (Silver Spring) 2018;26(1):6169
